Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination.

As expected, all of these findings were accompanied by a highly significant difference in overall survival between the CTC groups (57.9 months for patients with CTCs <5 CTCs/7.5 ml versus 27.3 months for those with ≥5 CTCs/7.5 ml; P = 0.0006).

also in 132,142 other papers